Jim Reilly | 2022 Veeva R&D and Quality Summit | Register Now

This video serves as a promotional invitation for the 2022 Veeva R&D and Quality Summit, highlighting the event’s return to an in-person format in Boston. The speaker, Jim Reilly, emphasizes the significance of the summit as a premier cross-industry gathering designed to connect thousands of peers, leaders, and experts across critical functions within the life sciences sector. The primary goal of the summit is to foster collaboration and idea sharing on how to advance the life sciences industry through technology and process innovation, underscoring the value of face-to-face interaction for building relationships and sharing insights.

The summit is positioned as a crucial meeting point for professionals working in clinical, quality and manufacturing, regulatory, safety, and IT departments. A major theme for the event is "Better Trials for All Through a Connected Clinical Ecosystem," signaling a strategic industry shift toward integrated technological platforms and streamlined processes in clinical development. This focus on connectivity aims to address challenges and drive better engagement from the perspectives of sponsors, investigative sites, and patients, recognizing that optimizing the trial experience requires holistic system integration.

To maximize interaction and knowledge exchange, the 2022 summit introduced several format changes. Notably, the event expanded its networking opportunities through "connect sessions," which are designed to break away from traditional presentation formats. These sessions prioritize small group idea sharing and focused networking, allowing attendees to delve deeper into specific challenges and solutions. Furthermore, the clinical zone was significantly expanded, offering specialized "trail maps" tailored to attendees' specific interests. These tracks include clinical operations, data management, randomization supply, and site and patient engagement, ensuring that participants receive targeted, relevant content aligned with their functional roles.

Key Takeaways: • Strategic Importance of the Veeva Ecosystem: The Veeva R&D and Quality Summit is identified as a premier, cross-industry event, signifying that Veeva’s platforms are central to the technological and operational strategies of pharmaceutical, biotech, and life sciences companies across R&D, Quality, Regulatory, and IT functions. • Focus on Connected Clinical Ecosystems: The central theme, "Better Trials for All Through a Connected Clinical Ecosystem," highlights the industry imperative to move away from siloed systems toward integrated technology solutions that link sponsors, sites, and patients for improved efficiency and data flow. • Prioritization of In-Person Interaction: After a period of virtual events, the emphasis on the return to in-person interaction underscores the recognized value of face-to-face networking for building robust professional relationships and accelerating collaborative innovation in technology and process development. • Expanded Networking Formats: The introduction of "connect sessions" moves beyond standard presentations, offering a model for structured small group idea sharing. This format is crucial for consultants and solution providers seeking deep, targeted engagement with potential clients and industry thought leaders. • Targeted Operational Tracks: The summit provides specialized "trail maps" catering to specific functional areas, including Clinical Operations, Data Management, Randomization Supply, and Site and Patient Engagement, indicating where the industry is focusing its immediate technological investment and process optimization efforts. • Multifunctional Audience Engagement: The event successfully brings together leaders and experts from diverse yet interconnected departments—Clinical, Quality, Manufacturing, Regulatory, Safety, and IT—reflecting the need for cross-functional alignment when implementing enterprise-wide technology solutions like those offered by Veeva. • Emphasis on Patient and Site Engagement: The specific inclusion of a track focused on "site and patient engagement" confirms that improving the user experience for clinical trial participants and investigative sites remains a high-priority area for technological innovation and process redesign. • Technology as an Enabler for Progress: The overarching message is that technology and process innovation are the primary drivers for bringing the life sciences industry forward, validating the need for AI and software solutions that streamline complex, regulated workflows.

Tools/Resources Mentioned:

• Veeva R&D and Quality Summit (Event)

Key Concepts:

• Connected Clinical Ecosystem: This concept refers to an integrated network of technology platforms (often Veeva Vault applications) that seamlessly link all stakeholders—sponsors, CROs, sites, and patients—involved in clinical trials. The goal is to improve data quality, accelerate trial timelines, and enhance the overall experience for participants and staff through unified processes and data sharing.